Today’s New Reality in Clinical Trial Readiness
We’ve talked about clinical trial readiness repeatedly in this space. Probably we all, as an industry, have a good sense of what that means —…
Kelly Ritch
Today’s New Reality in Clinical Trial Readiness
We’ve talked about clinical trial readiness repeatedly in this space. Probably we all, as an…
Kelly Ritch
Our Collective Response to COVID-19
We are all finding ways personally and professionally to meet the challenge posed by COVID-19. …
Joel Selzer
Interview: One ClinOps Leader Tells His Story on Site Preparedness, and Offers the Industry Some Advice
We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based…
Kelly Ritch
We Can and Must Help #StopTheSpread
The threat of Coronavirus (COVID-19) is real and spreading. The most vulnerable among us (the…
Joel Selzer
Are You About to Launch a Clinical Trial? Pump Your Brakes.
As the coronavirus continues to spread and dominate the media, we are inundated with advice…
Kelly Ritch
One Key Approach to Reducing Risk in Clinical Operations
There are many ways a clinical trial can go wrong: There might be delays in site identification, initiation, or…
Kelly Ritch
Pandemics Like Coronavirus Could Provide A Watershed Moment for Clinical Research
Above image: countries with confirmed COVID-19 cases as of March 10th. Credit: CDC.gov Below image:…
Joel Selzer
Interview: Managing Studies In A Rapidly Changing Treatment Environment
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech…
Kelly Ritch
Recapping the Conversations at SCOPE 2020
After record attendance and a high energy atmosphere at SCOPE 2020 in Orlando last week,…
Joel Selzer
[Interview] Increasing Study Confidence In the Eyes of a CRO Executive
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical…
Kelly Ritch
Industry insights you won’t delete. Delivered to your inbox weekly.
Join the Conversation at SCOPE with ArcheMedX
SCOPE 2020 is almost upon us! This year, ArcheMedX is helping to shape the conversation…
Joel Selzer
[Interview] Keeping It Personal: CRO Executive Uncovers the Value of Analytics in the Management of Clinical Trials
Wecome to another issue of our interview series Conversations in Clinical Trial Readiness, by ArcheMedX.…
Kelly Ritch
Evaluating Risk: Is Your Staff Clinical Trial Ready?
Does this scenario ring a bell? Your trial is about to go live - and…
Kelly Ritch
How Clinical Operations Teams Can Improve Trial Readiness Through Training in 2020.
There’s a new year underway. What can we do in 2020 to advance the success…
Kelly Ritch
[Interview] New Directions in Clinical Trial Preparation and Preparedness
We recently talked with Atlantic Research Group (ARG) executives Shay Brill, VP at ARG, and Erin Farris, Senior Director Project Management, about clinical trial operations, how they…
Kelly Ritch
[Interview] Moving the Chess Pieces: A Merck Exec’s Take on the Art of Staffing Clinical Trial Projects
We recently talked with Adam Kinsey, Executive Director, Clinical Sciences and Study Management—Oncology at Merck,…
Kelly Ritch
Experience ArcheMedX For Yourself
See how the ArcheMedX Platform can transform your organization’s learning and insights